(Marketwired – March 25, 2014) – Maple Leaf Green World (TSX VENTURE:MGW) (“Maple Leaf” or the “Company”) announces that it has engaged a professional consulting group to advise on opportunities to obtain an MMPR License (Marijuana for Medical Purposes Regulation License) from Health Canada and follow on business opportunities.
Maple Leaf has determined that given the knowledge and years of experience that its personnel have in greenhouse operations, and combined with its soil enhancement technology partnership, it is well positioned to consider licensed business opportunities in Canada to grow top quality marijuana and to pursue in the medical marijuana business.
Maple Leaf’s objective is to acquire requisite licences and facilities to grow pesticide free, top grade marijuana from contamination-free soil. Management believes that the knowledge and expertise accumulated through years of experience in greenhouse operations combined with the soil enhancement technology, provides a solid basis of experience for the Company.
Health Canada estimates that the medical marijuana market could be worth as much as $1.3 billion Cdn by 2024. Analysts and industry experts speculate that the new commercial marijuana business could reach $2.6 billion by 2016. Medical marijuana is currently legal in 20 U.S. states and several other states are considering both medical and recreational legalization of marijuana which provides an opportunity for quality Canadian growers to expand south.
The Company has not yet entered into any agreements in connection with the operation of a medical marijuana business.
There is no assurance that the Company will be qualified to seek requisite licences and if so, will be able to obtain such licences. Additionally, there is no assurance that the Company will be able to acquire the required assets to become a grower of medical marijuana, if licensed to do so.